Dan Strange, PhD profile page

For 15 years, Dr. Dan Strange has worked at the intersection of engineering and biology. Strange carried out his PhD at Cambridge University, designing and automating tissue engineering bioprocesses. He then moved to TTP where he worked with clients to invent, design and develop medical devices before joining TTP’s cell and gene group to focus on automation, tools and technologies for cell therapy manufacturing. He has been involved in the development of five modular manufacturing systems ranging from cell selection to expansion. Strange is now CTO of Cellular Origins where he is passionate about enabling patient access to cell therapies at scale through scalable, cost-effective and space-efficient manufacturing enabled by the Constellation™ automated cell therapy manufacturing platform.